MT
Michael Thomas Heffernan sold $596K of TRVI stock
Michael Thomas Heffernan, Dir of Trevi Therapeutics, Inc. (TRVI), sold 39,473 shares of TRVI stock worth $596K, per an SEC Form 4 filed Sep 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 15, 2026, 2 days before it was made public.
TRVI has moved -9.2% since the trade date, from $15.04 to $13.65 (Nov 13, 2026 close).
- Traded
- Sep 15, 2026
- Disclosed
- Sep 17, 2026
- Filing delay
- 2 days
- Price since
- -9.2%
- Role
- Dir
- Source
- SEC Form 4